U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686679) titled 'A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia' on June 30.
Brief Summary: This study will evaluate the efficacy and safety of DA-9701 in patients with functional dyspepsia
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Functional Dyspepsia
Intervention:
DRUG: DA-9701
1 tablet, TID
DRUG: DA-9701-R
1 tablet, TID
DRUG: DA-9701 Placebo
1 tablet, TID
DRUG: DA-9701-R Placebo
1 tablet, TID
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Dong-A ST Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....